Vericel (VCEL) Misses Q1 EPS by 3c, Revenues Beat; Raises FY21 Revenues Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. NDAQ
6. QS
7. BRO
8. BFH
9. SAP
10. AVEX

Go back to Vericel (VCEL) Misses Q1 EPS by 3c, Revenues Beat; Raises FY21 Revenues Guidance Above Consensus

Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance

May 5, 2021 7:00 AM EDT

First Quarter Total Net Revenue Increased 30% to $34.6 Million

Full-Year 2021 Revenue Guidance Raised to $165-$168 Million

Conference Call Today at 8:30am Eastern Time

CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the first quarter ended March 31, 2021.

First Quarter 2021 Financial Highlights

Total net revenue increased 30% to $34.6... More